With the advent of antimicrobial resistance, there is an urgent need for new strategies to treat infectious diseases. Antimicrobial peptides are considered as promising candidates, and therefore there is a need to understand their mechanism of action in order to exploit their therapeutic potential. To this end, fluorescent analogs are powerful tools to analyze their behavior and subcellular localization in cells and in vivo. However, the conjugation of fluorophores to antimicrobial peptides, especially in short sequences, can impair their biological activity, making the selection of the fluorescent label an essential step in these studies. In the present work, we have systematically modified a model antifungal hexapeptide with a collection of fluorophores covering broad physicochemical and spectral properties. The resulting conjugates have been examined in two different fungal species, in terms of their activity and intracellular localization. The biological results confirm the influence of the different fluorescent moieties on the subcellular localization of antimicrobial sequences, and provides an insight on the optimal fluorophores to be used in the preparation of fluorescent peptides for different bioimaging assays.
Introduction
In the past decades, fluorescent dyes have been broadly used as tags to visualize and study the roles of peptides in cells and in vivo. 1 For these studies, live cell imaging has become the technology of choice as it provides a direct readout of the localization of the peptides with high spatial and temporal resolution. In the context of antimicrobial peptides, several reports have described fluorescence labeling as an approach to study their mechanism of action [2] [3] [4] as well as to develop imaging probes for the rapid identification of microbes at infection sites. 5 In all cases, it is often assumed that fluorescently labeled peptides faithfully mimic the spatio-temporal dynamics of the native peptides, and fluorescent labels are typically chosen on the basis of excitation/emission wavelength, quantum yield, photobleaching, environmental sensitivity or chemical conjugation. Little attention has been paid to whether the fluorescent label might alter the physicochemical properties of the conjugate, and it is often unclear whether the fluorescent tag influences the uptake and localization of antimicrobial peptides inside living cells. In order to evaluate the impact that different fluorophores have in the biological properties of antimicrobial peptides and their application as imaging probes, we have synthesized a library of fluorescent conjugates based on the Peptide Antifungal 26 (PAF26). 6 This rationally designed hexapeptide exhibits high potency against filamentous fungi (including human and crop pathogens), low toxicity against bacterial cells and negligible toxicity against mammalian cells. PAF26 is currently being used a model peptide for the characterization of the mode-of-action of small, cationic, cell penetrating antifungal peptides and for the design and development of synthetic antifungal peptides with improved properties for therapeutic uses. 7 In the present work, we have conjugated 12 different fluorophores (either in-house or commercially available) to the peptide sequence of PAF26 and compared their biological activity, cellular uptake and intracellular localization using confocal live cell imaging. From these studies, we have observed that the activity of the conjugates is practically unaffected by the fluorescent labels whereas they accumulate in different intracellular regions depending on the fluorophore attached to the sequence. This systematic study will aid chemists working on peptide-based imaging agents in the selection of the fluorophores for different fluorescence-based biological applications.
Results and Discussion

Design and synthesis of a library of fluorescent antifungal peptides
For many years, the synthesis of antimicrobial peptides has been adapted to combinatorial chemistry. However, libraries of antimicrobial peptides have been mainly focused on the optimization of the peptide sequences, either to enhance their antimicrobial activity, improve their selectivity against specific strains or pathogens, or to reduce their cytotoxicity in mammalian cells. [8] [9] [10] Some antimicrobial peptides have been labeled with fluorophores in order to visualize their localization in cells by confocal microscopy. 4, 11 More recently, the high selectivity of antimicrobial sequences has been exploited to develop imaging contrast agents for the rapid identification of infection sites. 12, 13 In most reports, only one fluorophore is employed on the basis of its compatibility with the experimental procedures. However, conventional fluorophores differ largely in their physicochemical features, 14, 15 and therefore it is reasonable to expect that different fluorophores could induce variability in the activity and cellular localization properties of peptide sequences. For instance, Baker et al. reported the influence of different fluorescent labels in a 5 combinatorial library of A1R adenosine inhibitors, where significant differences were observed in the binding properties of several fluorescently-labeled inhibitors. 16 In the context of short antimicrobial peptides, there are no reports of any systematic evaluation of their biological properties after conjugation to various fluorescent labels. Herein, we have designed a library based on the antimicrobial peptide sequence PAF26, which was modified with a total of 12 fluorophores covering the whole spectral range (from blue to near-infrared emission) and diverse physicochemical properties (Chart 1). In addition to conventional fluorophores (e.g. carboxyfluorescein, carboxyrhodamine, BODIPY, cyanine), we also included small fluorophores (e.g. NBD, dansyl), compounds with environmentally-sensitive properties (e.g. Nile Blue, malachite green, styryl), pH-sensitivity (e.g. naphthalimide) and esterase-activatable fluorophores (e.g. fluorescein diacetate). Overall, these fluorophores constitute a representative collection of the fluorescent labels that most chemists would employ for labeling any defined peptide sequence. 6 Chart 1. Fluorescent labels for the derivatization of the antimicrobial peptide PAF26. We employed 12 different fluorophores with suitable reactive groups (in red) for peptide labeling (e.g. carboxylic acids, sulfonyl chlorides, anhydrides, alkynes). Fluorophores 1, 2, 3 and 7 are commercially available, whereas the synthesis and characterization of all other fluorophores is described in the Experimental Procedures and the Electronic Supplementary Information (ESI).
PAF26 (H-RKKWFW-NH2) is a short antimicrobial peptide which, like many other antimicrobial peptides, contains both cationic and hydrophobic residues, 6,7 and therefore it is an excellent model for examining the influence of fluorophores in the properties of antimicrobial peptides. We 7 designed the synthesis of the hexapeptide using conventional solid-phase protocols in Rink amide polystyrene resin (Scheme 1). In order to incorporate suitable conjugation groups within the sequence of PAF26, we first synthesized two derivatives containing aminohexanoic or azidohexanoic spacers directly attached to the N-terminal group of PAF26. Through these spacers, fluorophores could be readily conjugated using their reactive groups (i.e., carboxylic acids, chlorides, anhydrides, sulfonyl chlorides or alkynes) without affecting the main recognition features of the antimicrobial peptide. Most library members were fully synthesized on solid support, including the coupling of the fluorophore, to render the final fluorescent PAF26 analogues upon acidic cleavage from the resin using reported procedures. 17 Due to the lability of the fluorophores 11 and 12 (i.e., BODIPY and fluorescein diacetate, respectively) to acidic media, the corresponding derivatives PAF26-11 and PAF26-12 were prepared by 1,3-Huisgen dipolar cycloaddition using the azido-modified PAF26 and the fluorescent alkynes in solution phase (Scheme 1). All 12 fluorescent derivatives of PAF26 were purified by semi-preparative HPLC to isolate the final conjugates (PAF26-1 to PAF26-12) in high purities (for characterization data, see ESI). 
In vitro biological activity of fluorescent antifungal peptides
After completing the synthesis of the library of fluorescent antimicrobial conjugates (PAF26-1 to PAF26-12), we measured their spectral properties and determined their IC50 values in two different fungal species (i.e., Neurospora crassa and Aspergillus fumigatus) as a measure of their cellular activity ( Table 1) . N. crassa has been widely used as an experimental model organism for filamentous fungi. 18 A. fumigatus is a very important opportunistic pathogen responsible for multiple human diseases, the most lethal of which, invasive pulmonary aspergillosis, causes around 200,000 deaths per year. 19 Conjugates incorporating small fluorophores (e.g., NBD (PAF26-3), naphthalimide (PAF26-4), dansyl (PAF26-7)) showed very similar antifungal activity when compared to the unlabeled sequence PAF26 in both fungal species. This observation is in line with previous reports where NBD or dansyl have been described as highly tolerated fluorescence labels for the derivatization of biomolecules. 20 Larger fluorophores, including positively-charged fluorophores [i.e. rhodamine (PAF26-1), Nile Blue (PAF26-6), styryl dyes (PAF26-8 and PAF26-9)] and fluorescein-based structures (PAF26-2 and PAF26-12) induced only minor differences in the antifungal activity of PAF26, with all IC50 values in the low micromolar range. Two conjugates (PAF26-10 and PAF26-11) showed slightly higher activity, being the two corresponding fluorophores [i.e. cyanine (10) and BODIPY (11)] permeable structures that have been reported for the preparation of a range of fluorescent probes. [21] [22] [23] [24] [25] Altogether, these results corroborate the minor influence of the fluorescence labels on the antifungal activity of fluorescent PAF26 conjugates, with the smallest impairment being observed for conjugates including small fluorophores. the rhodamine fluorophore might favour the interaction with the negatively charged phospholipids in the plasma membrane. In contrast, the carboxyfluorescein derivative PAF26-2 showed a similar pattern of intracellular vacuolar distribution but reduced staining on the cell envelope ( Fig. 1 ). The negative charge of carboxyfluorescein reduced the affinity of the conjugate for the cell envelope, with slower internalization (Table 1) . Similarly, the diacetylated derivative (PAF26-12) showed preferential staining of the vacuolar lumens with no fluorescence detected in the plasma or intracellular membranes, because its fluorescence emission is triggered upon reaction with intracellular esterases ( vacuoles), in which these fluorophores exhibit very low quantum yields. 26, 27 On the other hand, cationic styryl-based fluorophores (PAF26-8 and PAF26-9) showed remarkably enhanced staining of the envelope of fungal cells. PAF26-8 brightly stained the plasma and intracellular vacuolar/vesicular membranes of N. crassa to a similar extent than PAF26-1 ( Fig.   1 ), but without marked accumulation in the vacuole lumens. Imaging experiments using the PAF26-9 derivative also showed a similar behavior in both N. crassa and A. fumigatus ( Fig. S5 in ESI). As observed for PAF26-1, the cationic character of the styryl fluorophores favoured the rapid interaction with anionic components of the cellular membranes and enhanced their internalization (Table 1) . Interestingly, and in contrast to the results obtained with N. crassa (Fig.   1 ), when we incubated PAF26-8 with A. fumigatus, we did not observe the uptake of the fluorescent conjugate into healthy cells and hyphae were only stained once the cell membrane structure was compromised ( Fig. S6 and Movie S1 in ESI). These results highlight differences in the internalization of PAF26-8 by cells of different fungal species, suggesting the possibility of using fluorescent labels as means to improve the selectivity of antimicrobial sequences.
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Finally, both cyanine and BODIPY-based conjugates (PAF26-10 and PAF26-11, respectively) displayed a markedly different staining pattern when compared to all other members of the PAF26 library. The cyanine derivative (PAF26-10) brightly stained fungal cells and, besides localizing within vacuoles and vesicle lumens, it also stained other cytoplasmic organelles. Dual labeling experiments with the carboxyfluorescein derivative PAF26-2 confirmed the presence of PAF26-10 in the same vacuolar and vesicular organelles but also indicated its localization in different cytoplasmic organelles (Fig. 2) . The BODIPY derivative PAF26-11 exhibited general staining of the cytoplasm with no specific accumulation in subcellular organelles, as shown by co-localization experiments with PAF26-1 (Fig. 2 ).
Furthermore, we compared the staining of N. crassa cells using the fluorescent peptides PAF26-1, PAF26-2, PAF26-10 and PAF26-11 and their corresponding fluorophores alone (Fig S7 in   ESI) . In these experiments, we observed that the PAF26 sequence is essential for the interaction, internalization and accumulation of the fluorescent conjugates in the vacuoles of fungal cells, as the fluorophores alone were not able to enter the cells or stained non-specifically intracellular environments (e.g. the BODIPY fluorophore showed bright, general staining of lipid-rich subcellular structures). Finally, in view of the bright fluorescence signals in fungal cells upon incubation with PAF26-10
( Figure 2A ) and its emission in the near-infrared region (em.: 660 nm, Table 1 ), we assessed the suitability of PAF26-10 for whole-body in vivo fluorescence imaging experiments in mice with fungal lung infection. Near-infrared fluorophores are advantageous for in vivo imaging as the low autofluorescence background in such region of the spectra enhances the signal-to-noise ratios. [28] [29] [30] We determined the background and fluorescence signals in mice that had been treated with PAF26-10, and observed that the cyanine fluorophore was bright enough to provide a detectable signal from live animals using whole-body fluorescence imaging ( Fig. S8 in ESI) . These results are in good agreement with previous reports of cyanine-labeled peptides for in vivo imaging of cancer cells in xenograft models. 31, 32 Altogether 
Conclusions
Fluorescently labeled peptides are powerful tools for image-based mechanistic studies in cells. N-(4-((4-carboxyphenyl)(4-(dimethylamino)phenyl) 
N-(5-(5-carboxybutanamido)-9H-benzo[a]phenoxazin-9-ylidene)-N-ethylethanaminium (6).
Nile Blue chloride (0.33 mmol) was dissolved in DCM together with glutaric anhydride (1 mmol) Hz, 3H), 0.93 (t, J = 7.4 Hz, 6H). 13 
